Alpha-1 Antitrypsin Deficiency Treatment Receives Orphan Drug Designation
In June 2019, Dicerna Pharmaceuticals submitted a clinical trial application for their DCR-A1AT therapy and expects to treat the first patient with A1AD-related liver disease near the end of…